Raft forming system-an upcoming approach of gastroretentive drug delivery system.

In recent era various technologies have been made in research and development of controlled release oral drug delivery system to overcome various physiological difficulties such as variation in gastric retention and emptying time. To overcome this drawback and to maximize the oral absorption of various drugs, novel drug delivery systems have been developed. Gastroretentive drug delivery system is facing many challenges which can be overcome by upcoming newly emerging approach i.e. raft forming system. The purpose of writing this review is to focus on recent development of stomach specific floating drug delivery system to circumvent the difficulties associated with formulation design. Various gastroretentive approaches that have been developed till now are also discussed. The present study provides valuable information & highlights advances in this raft forming system. This review attempts to discuss various factors like physiological factors, physicochemical factors and formulation factors to be considered in the development of the raft forming system. Different types of smart polymers used for their formulation have also been summarized. The review focuses on the mechanism, formulation and development of the raft forming system. This review also summarizes the studies to evaluate the performance and application of these systems. The study finally highlights advantages, disadvantages, and marketed preparation of the raft forming system.

[1]  J. Newton,et al.  Gastrointestinal transit of pellets of differing size and density , 1993 .

[2]  B. Mishra,et al.  Floating in situ gelling system for stomach site-specific delivery of clarithromycin to eradicate H. pylori. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[3]  Edith Mathiowitz,et al.  Encyclopedia of Controlled Drug Delivery , 1999 .

[4]  S. K. Chaturvedi,et al.  A comprehensive review on floating oral drug delivery system , 2011 .

[5]  J D Smart,et al.  An in‐vitro investigation of mucosa‐adhesive materials for use in controlled drug delivery , 1984, The Journal of pharmacy and pharmacology.

[6]  N A Peppas,et al.  Dynamic behavior of glucose oxidase-containing microparticles of poly(ethylene glycol)-grafted cationic hydrogels in an environment of changing pH. , 2000, Biomaterials.

[7]  K. Ladefoged,et al.  Distribution of pellets in the gastrointestinal tract. The influence on transit time exerted by the density or diameter of pellets , 1978, The Journal of pharmacy and pharmacology.

[8]  Rizwana Khan,et al.  GASTRORETENTIVE DRUG DELIVERY SYSTEM - A REVIEW , 2013 .

[9]  Tsuneji Nagai,et al.  Magnetic granules: a novel system for specific drug delivery to esophageal mucosa in oral administration , 1990 .

[10]  P. R. Sheth,et al.  The Hydrodynamically Balanced System (Hbs™): A Novel Drug Delivery System for Oral Use , 1984 .

[11]  J. Hamman,et al.  Polymeric Plant-derived Excipients in Drug Delivery , 2009, Molecules.

[12]  S. K. Patel,et al.  STOMACH SPECIFIC FLOATING DRUG DELIVERY SYSTEM: A REVIEW , 2009 .

[13]  Ami Makwana,et al.  ADVANCEMENTS IN CONTROLLED RELEASE GASTRORETENTIVE DRUG DELIVERY SYSTEM: A REVIEW , 2012 .

[14]  Gan-Lin Chen,et al.  In vitro performance of floating sustained-release capsule of verapamil. , 1998, Drug development and industrial pharmacy.

[15]  Tsuneji Nagai,et al.  Preparation of a magnetically-responsive tablet and confirmation of its gastric residence in beagle dogs , 1994 .

[16]  L. C. Feely,et al.  Gastrointestinal transit of non-disintegrating tablets in fed subjects , 1989 .

[17]  R. Fassihi,et al.  Gastroretentive Delivery Systems: Hollow Beads , 2004, Drug development and industrial pharmacy.

[18]  Kenneth C. Waterman A Critical Review of Gastric Retentive Controlled Drug Delivery , 2007, Pharmaceutical development and technology.

[19]  J. Kister,et al.  An innovative floating gastro retentive dosage system: formulation and in vitro evaluation. , 2009, International journal of pharmaceutics.

[20]  Biswarup Das,et al.  Gastroretentive drug delivery systems: a review , 2010 .

[21]  H. Sharma,et al.  An investigation of the parameters influencing the bioadhesive properties of Myverol 18-99/water gels. , 1997, Biomaterials.

[22]  Raymond C Rowe,et al.  Handbook of Pharmaceutical Excipients , 1994 .

[23]  Arvind K. Bansal,et al.  A Means to Address Regional Variability in Intestinal Drug Absorption , 2003 .

[24]  D. Attwood,et al.  In Situ Gelling Pectin Formulations for Oral Sustained Delivery of Paracetamol , 2004, Drug development and industrial pharmacy.

[25]  Kinam Park,et al.  Gastric retentive drug-delivery systems. , 1998, Critical reviews in therapeutic drug carrier systems.

[26]  G. Kankal REVIEW ON- GASTRORETENTIVE DRUG DELIVERY SYSTEM , 2013 .

[27]  R. Bodmeier,et al.  Floating or pulsatile drug delivery systems based on coated effervescent cores. , 1999, International journal of pharmaceutics.

[28]  Juergen Siepmann,et al.  Drug delivery to the upper small intestine window using gastroretentive technologies. , 2006, Current opinion in pharmacology.

[29]  G. K. Jani,et al.  A Newer Application of Physically Modified Gellan Gum in Tablet Formulation using Factorial Design , 2010 .

[30]  K. M. Khritov,et al.  Experiment, Theory and Application , 2002 .

[31]  G. W. Skinner,et al.  Pharmaceutical applications of naturally occurring water-soluble polymers , 1998 .

[32]  H. G. Schild Poly(N-isopropylacrylamide): experiment, theory and application , 1992 .

[33]  H. K. Ibrahim A novel liquid effervescent floating delivery system for sustained drug delivery. , 2009, Drug discoveries & therapeutics.

[34]  S. Shruti A Review On: Recent Advancement of Stomach Specific Floating Drug Delivery System , 2011 .

[35]  A. Handa,et al.  Chemistry and uses of pectin--a review. , 1997, Critical reviews in food science and nutrition.

[36]  P. Chaudhary APPROACHES FOR GASTRORETENTIVE DRUG DELIVERY SYSTEMS-A REVIEW , 2014 .

[37]  R. Garg,et al.  Progress in Controlled Gastroretentive Delivery Systems , 2008 .

[38]  R. Qaqish,et al.  Evaluation of the Factors Influencing Stomach‐specific Delivery of Antibacterial Agents for Helicobacter pylori Infection , 1999, The Journal of pharmacy and pharmacology.

[39]  M. Georgarakis,et al.  Acyclovir serum concentrations following peroral administration of magnetic depot tablets and the influence of extracorporal magnets to control gastrointestinal transit. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[40]  Yie W. Chien,et al.  Novel Drug Delivery Systems , 1991 .

[41]  O. Wichterle,et al.  Hydrophilic Gels for Biological Use , 1960, Nature.

[42]  M. Amiji,et al.  Stomach-specific anti-H. pylori therapy. I: Preparation and characterization of tetracyline-loaded chitosan microspheres. , 2002, International journal of pharmaceutics.

[43]  W. Sawicki Pharmacokinetics of verapamil and norverapamil from controlled release floating pellets in humans. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[44]  Masaki Ichikawa,et al.  A new multiple-unit oral floating dosage system. I: Preparation and in vitro evaluation of floating and sustained-release characteristics. , 1991, Journal of pharmaceutical sciences.

[45]  P. Thapa,et al.  An Overview of the Gastroretentive Drug Delivery System , 2023, International Journal of Pharmaceutical Sciences Review and Research.

[46]  Javed Ali,et al.  Floating drug delivery systems: A review , 2005, AAPS PharmSciTech.

[47]  Kinam Park,et al.  Bioadhesive polymers as platforms for oral-controlled drug delivery: method to study bioadhesion , 1984 .

[48]  E. Doelker,et al.  Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery , 1996 .

[49]  Neena Washington,et al.  Investigation into the Barrier Action of an Alginate Gastric Reflux Suppressant, Liquid Gaviscon® , 1990 .

[50]  P. Upadhyay,et al.  In Situ Gel: A Novel Approach of Gastroretentive Drug Delivery , 2012 .

[51]  Brahma N. Singh,et al.  Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[52]  J. L. Fábregas,et al.  “In-Vitro” Testing of an Antacid Formulation with Prolonged Gastric Residence Time (Almagate Flot-Coat®) , 1994 .

[53]  D. Attwood,et al.  In situ-gelling gellan formulations as vehicles for oral drug delivery. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[54]  L. Yang,et al.  Zero-order release kinetics from a self-correcting floatable asymmetric configuration drug delivery system. , 1996, Journal of pharmaceutical sciences.

[55]  J. Timmermans,et al.  How well do floating dosage forms float , 1990 .

[56]  A. Székács,et al.  Hydrolysis of Carbonates, Thiocarbonates, Carbamates, and Carboxylic Esters of α-Naphthol, β-Naphthol, and p-Nitrophenol by Human, Rat, and Mouse Liver Carboxylesterases , 1993, Pharmaceutical Research.

[57]  C. Sébastian,et al.  A new long acting ophthalmic formulation of carteolol containing alginic acid. , 2000, International journal of pharmaceutics.

[58]  F. N. Christensen,et al.  The effect of density on the gastric emptying of single- and multiple-unit dosage forms , 1986, Pharmaceutical Research.

[59]  M. Helliwell The use of bioadhesives in targeted delivery within the gastrointestinal tract , 1993 .

[60]  P. M’s,et al.  In-Situ gel: New trends in Controlled and Sustained Drug Delivery System , 2003 .

[61]  J. B. Park,et al.  Preparation of alginate beads for floating drug delivery system: effects of CO(2) gas-forming agents. , 2002, International journal of pharmaceutics.

[62]  Mandel Kg,et al.  Review article : Alginate-raft formulations in the treatment of heartburn and acid reflux , 2000 .

[63]  N. Moulai-Mostefa,et al.  Structural characterization and surface activity of hydrophobically functionalized extracted pectins , 2009 .

[64]  Y. Aramaki,et al.  Drug release from pH-response polyvinylacetal diethylaminoacetate hydrogel, and application to nasal delivery , 1998 .

[65]  D. Attwood,et al.  Xyloglucan gels as sustained release vehicles for the intraperitoneal administration of mitomycin C , 1998 .

[66]  Kinam Park,et al.  Gastric retention properties of superporous hydrogel composites. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[67]  Parviz Mojaverian,et al.  Effects of Gender, Posture, and Age on Gastric Residence Time of an Indigestible Solid: Pharmaceutical Considerations , 1988, Pharmaceutical Research.

[68]  F. Atyabi,et al.  Controlled drug release from coated floating ion exchange resin beads , 1996 .

[69]  E. Morris,et al.  Thermally reversible acid-induced gelation of low-methoxy pectin , 2000 .

[70]  L. Balant,et al.  Comparative pharmacokinetic study of a floating multiple-unit capsule, a high-density multiple-unit capsule and an immediate-release tablet containing 25 mg atenolol. , 1998, Pharmaceutica acta Helvetiae.

[71]  R. Murthy,et al.  Floating dosage systems in drug delivery. , 2002, Critical reviews in therapeutic drug carrier systems.

[72]  Kinam Park,et al.  Synthesis and characterization of superporous hydrogel composites. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[73]  Jacoby,et al.  Review article: alginate‐raft formulations in the treatment of heartburn and acid reflux , 2000, Alimentary pharmacology & therapeutics.

[74]  K. Anseth,et al.  A review of photocrosslinked polyanhydrides: in situ forming degradable networks. , 2000, Biomaterials.

[75]  V. Cowles,et al.  Gastric retentive dosage forms: a review. , 2003, Critical reviews in therapeutic drug carrier systems.

[76]  A. Srinatha,et al.  In Situ Forming Formulation: Development, Evaluation, and Optimization Using 33 Factorial Design , 2009, AAPS PharmSciTech.

[77]  P Ramarao,et al.  Design and evaluation of biodegradable, biosensitive in situ gelling system for pulsatile delivery of insulin. , 2007, Biomaterials.

[78]  Y. Kawashima,et al.  Hollow microspheres for use as a floating controlled drug delivery system in the stomach. , 1992, Journal of pharmaceutical sciences.

[79]  H. Zia,et al.  Mucoadhesive Drug Delivery Systems , 1993 .

[80]  V. Sinha,et al.  Polysaccharides in colon-specific drug delivery. , 2001, International journal of pharmaceutics.

[81]  Javed Ali,et al.  Formulation and development of hydrodynamically balanced system for metformin: in vitro and in vivo evaluation. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[82]  A. Gaur,et al.  Formulation and Evaluation of Sodium Alginate Based In-Situ Gel Drug Delivery System of Famotidine , 2011 .

[83]  B. Mishra,et al.  Development and evaluation of a novel floating in situ gelling system of amoxicillin for eradication of Helicobacter pylori. , 2007, International journal of pharmaceutics.

[84]  M. Berntgen,et al.  Estimation of the gastric residence time of magnetic dosage forms using the Heidelberg capsule. , 1996, Die Pharmazie.

[85]  Y. Kawashima,et al.  In vitro and in vivo evaluation of riboflavin-containing microballoons for a floating controlled drug delivery system in healthy humans. , 2004, International journal of pharmaceutics.

[86]  Guojie Xu,et al.  Effect of FITC‐dextran molecular weight on its release from floating cetyl alcohol and HPMC tablets , 2001, The Journal of pharmacy and pharmacology.

[87]  S. Suresh,et al.  Nasal drug delivery : An overview , 2005 .

[88]  Rishabha Malviya,et al.  Gastroretentive Drug Delivery Systems : A Review , 2014 .

[89]  D. Bhavsar ADVANCES IN GRDDS: RAFT FORMING SYSTEM A REVIEW , 2012 .

[90]  M. Dentini,et al.  Solution and Gelling Properties of Microbial Polysaccharides of Industrial Interest : The Case of Gellan , 1990 .

[91]  N. Udupa,et al.  Biodegradable Injectable Implant Systems for Long Term Drug Delivery Using Poly (Lactic‐co‐glycolic) Acid Copolymers , 1996, The Journal of pharmacy and pharmacology.

[92]  K. Gujar,et al.  --------------------------------------------------------------------------------------------------------------------------------------------------STOMACH SPECIFIC DRUG DELIVERY SYSTEMS : A REVIEW , 2012 .

[93]  S. Ochi,et al.  Sustained release liquid preparation using sodium alginate for eradication of Helicobacter pyroli. , 1999, Biological & pharmaceutical bulletin.

[94]  T. Bhardwaj,et al.  Natural Gums and Modified Natural Gums as Sustained-Release Carriers , 2000, Drug development and industrial pharmacy.

[95]  D A Rüfenacht,et al.  In vitro assessment of new embolic liquids prepared from preformed polymers and water-miscible solvents for aneurysm treatment. , 2000, Biomaterials.

[96]  D. Attwood,et al.  Comparison of in situ gelling formulations for the oral delivery of cimetidine. , 2001, International journal of pharmaceutics.

[97]  A. Ojha,et al.  Review on Gastro Retentive Drug Delivery System , 2012 .

[98]  P. Deasy,et al.  In vitro and in vivo evaluation of an oral sustained-release floating dosage form of amoxycillin trihydrate , 1992 .

[99]  J. Irache,et al.  Specific and non-specific bioadhesive particulate systems for oral delivery to the gastrointestinal tract. , 1998, Advanced drug delivery reviews.

[100]  J. Fell,et al.  Development of a gastroretentive dosage form. , 1996 .

[101]  Purnima Tripathi,et al.  FLOATING DRUG DELIVERY SYSTEM , 2012 .

[102]  Rayat,et al.  FLOATING DRUG DELIVERY SYSTEM: A REVIEW , 2022, International Journal of Advanced Research.

[103]  A. Chenthilnathan,et al.  Floating Drug Delivery Systems: A Review , 2011 .

[104]  S. Sarojini,et al.  An overview on various approaches to Gastroretentive dosage forms , 2012 .